Diabetes care devices are used in the treatment and management of diabetes. Insulin delivery devices are used to inject measured doses of insulin through the skin and into the fatty tissues below. An insulin pump is an insulin delivery device that administers programmed doses of insulin for diabetes management. A blood glucose meter is an electronic diabetic management device used for measuring blood glucose levels. GlobalData uses proprietary data and analytics to provide a comprehensive report on the insulin pumps and continuous glucose monitors devices market, including market shares of different players within China. Buy the latest report here.
Smarter leaders trust GlobalData
In 2021, GlobalData’s Market Model methodology determined that the leading player in the insulin pumps and continuous glucose monitors market in China was Medtronic followed by F. Hoffmann-La Roche, Insulet, Abbott Laboratories and DexCom.
The insulin pump consists of a battery run pump, an insulin reservoir and an infusion set with a tubing system for subcutaneous intervention. Traditional Insulin Pumps & Accessories and patch pumps are tracked under this segment. The Continuous glucose monitoring system includes an implantable sensor with wireless transmission capability and a monitor. The Continuous glucose monitoring system includes an implantable sensor with wireless transmission capability and a monitor.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the insulin pumps and continuous glucose monitors devices market within China was expected to be over $600m in 2021.
For the latest complete market share analysis of insulin pumps and continuous glucose monitors device market in China, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
